Harry de Koning

Harry de Koning is a Full Professor in the Department of Public Health at Erasmus MC, where he leads research in cancer screening and public health policy. His work is highly influential in shaping national and international guidelines for early cancer detection.

His primary research interests include lung cancer screening, breast cancer screening, cost-effectiveness analysis, and population health. He has published extensively on the economic and clinical impacts of screening programs, with a strong focus on reducing cancer mortality through evidence-based interventions.

Recent publications highlight a shift toward integrating artificial intelligence in public health screening and advocating for comprehensive CT-based screening frameworks globally. His work on HPV vaccination programs demonstrates measurable improvements in cervical screening outcomes, influencing policy in European countries.

Harry de Koning has supervised 44 research projects, indicating a significant role in mentoring the next generation of public health researchers. He collaborates extensively with international experts in oncology, radiology, and health economics.

His research has been featured in high-impact journals such as The Lancet Regional Health - Europe and European Journal of Cancer, and has received attention from news outlets, social media, and academic platforms like Mendeley.